July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
OCTA and beyond: Qualitative Revelations and Opportunities in Quantitative Imaging
Author Affiliations & Notes
  • Richard B Rosen
    Ophthalmology, New York Eye & Ear Infirmary, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Footnotes
    Commercial Relationships   Richard Rosen, Astellas (C), Boehringer- Ingelheim (C), CellView (C), Diopsys (C), Genetech (F), Guardion (I), NanoRetina (C), OD-OS (C), Opticology (I), Optovue (C), Regeneron (C), Teva (C), Zeavision (C)
  • Footnotes
    Support  NEI U01 EY025477-01, NEI R01EY027301, ECRIP Award 2017-2019, Marrus Family Foundation, Wise Family Foundation, Lowenstein Foundation, Millbank Foundation, Dennis Gierhart Foundation, NYEEI Chairman’s Fund, Geraldine Violett Fund, NYEEI research Foundation
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 997. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Richard B Rosen; OCTA and beyond: Qualitative Revelations and Opportunities in Quantitative Imaging. Invest. Ophthalmol. Vis. Sci. 2019;60(9):997.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : OCT Angiography represents a paradigm shift of our ability to clinically investigate the retinal microvasculature. It provides immediate non-invasive access to capillary beds allowing a clearer understanding of macular and optic nerve pathologies which accompany or precede retinal structural changes. Beyond qualitative anatomic imaging, it offers the unique capability of quantitative analysis for measuring subtle progression of disease, as well as the metabolic impact of traumatic events and therapeutic interventions. Examples of its use in investigating the perfusion impact of acute intraocular pressure events, neurologic episodes, and therapeutic interventions will be discussed. Strategies for identifying early pathological changes from normal variations in perfusion will also be presented.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×